Search Results
Sep 01, 2026, 12:26 ET Guggenheim Strategic Opportunities Fund (GOF) Faces Investor Scrutiny Amid Report On Distributions Funding, Portfolio Quality - HBSS
www.hbsslaw.com/gof Contact the Firm Now: [email protected] 844-916-0895Guggenheim Strategic Opportunities Fund (GOF) Investigation:Hagens
More news about: Hagens Berman Sobol Shapiro LLP
Aug 28, 2026, 13:05 ET Guggenheim Strategic Opportunities Fund (GOF) Faces Investor Scrutiny Amid Report On Distributions Funding, Portfolio Quality - HBSS
www.hbsslaw.com/gofGuggenheim Strategic Opportunities Fund (GOF) Investigation:Hagens Berman has opened its investigation because of some potentially serious accusations
More news about: Hagens Berman Sobol Shapiro LLP
Aug 05, 2026, 08:00 ET Neurvati Neurosciences Strengthens Executive Leadership Team to Advance Next Phase of Growth at GRIN Therapeutics
identifier: NCT05818943) evaluating investigational radiprodil in GRIN-related neurodevelopmental disorder (GRIN-NDD) in patients with gain-of-function (GoF) variants, leading to the decision to advance to the global Phase 3 Beeline trial (ClinicalTrials.gov identifier:
More news about: Neurvati Neurosciences
May 05, 2026, 08:00 ET CLARK DEAN UNVEILS THE GEORGIA OPERATIONAL FRAMEWORK: A NEW ERA OF GOVERNMENT TRANSFORMATION
May. 5, 2026 /PRNewswire/ -- Clark Dean, Republican candidate for Governor of Georgia, today unveiled the Georgia Operational Framework ("GOF")—a comprehensive, expert-designed plan to fundamentally transform how Georgia state government operates, delivers services, and serves its citizens.
More news about: Clark Dean for Governor
May 04, 2026, 07:00 ET GRIN Therapeutics' Pivotal Phase 3 Beeline Study Initiated in Europe
of radiprodil, a selective negative allosteric modulator of the NMDA receptor GluN2B subunit, in patients with GRIN-NDD caused by gain-of-function (GoF) variants. By targeting the underlying biology of NMDA receptor overactivation, radiprodil has the potential to address core aspects of the disease,
More news about: GRIN Therapeutics Inc.
Feb 02, 2026, 01:00 ET Discover the Excellence of European and Italian Canned Tomatoes
nutritious, vegetarian-friendly creations honoring both regional tastes and individual preferences.Ingredients:400gof Italian canned whole peeled tomatoes2 large aubergine, sliced into rounds1 large onion, finely chopped3 cloves garlic, minced60
More news about: Red Gold from Europe
Jan 09, 2026, 07:30 ET GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder
identifier: NCT05818943) evaluating investigational radiprodil in GRIN-related neurodevelopmental disorder (GRIN-NDD) in patients with gain-of-function (GoF) variants, leading to the decision to advance to the global pivotal Phase 3 Beeline trial (ClinicalTrials.gov identifier:
More news about: GRIN Therapeutics Inc.
Dec 03, 2025, 07:00 ET GRIN Therapeutics to Present on Global Phase 3 Beeline Clinical Trial of Radiprodil at American Epilepsy Society Annual Meeting
identifier: NCT05818943) evaluating investigational radiprodil in GRIN-related neurodevelopmental disorder (GRIN-NDD) in patients with gain-of-function (GoF) variants, leading to the decision to advance to a global pivotal Phase 3 trial. The company has an additional ongoing clinical trial to evaluate radiprodil
More news about: GRIN Therapeutics Inc.
Nov 13, 2025, 07:00 ET Neurvati Neurosciences Appoints Carlos Martin as Chief Commercial Officer
identifier: NCT05818943) evaluating investigational radiprodil in GRIN-related neurodevelopmental disorder (GRIN-NDD) in patients with gain-of-function (GoF) variants, leading to the decision to advance to a global pivotal Phase 3 trial. The company has an additional ongoing clinical trial to evaluate radiprodil
More news about: Neurvati Neurosciences